Clinical Laboratory Scientist

Rana Zahedi

Phone: 617-***-****; E-mail: **********@*****.***

Summary

Supervisor in CLIA (Clinical Laboratory Improvement Amendment)-regulated laboratories for 8 years as unit chief. Research Scientist for 17 years in CLIA-approved laboratories at California department of public health Biomonitoring unit, center for blood research and Lawrence Berkeley National laboratory. Supervising Chemists in Chemistry and Molecular Diagnostic laboratories at State of California; monitoring State-contractor laboratory performance; prepares and organizes records for compliance with State (California Code of Regulations and Legislative Information) and CLIA requirements (Chapter 17 and 42 CFR Part 493); Developing method and testing in Biomonitoring section of environmental Chemistry laboratory & Genetic disease laboratories. Involved in the implementation Lysosomal Storage Disorders (LSD) screening test for Newborns. Development and validation of analytical method for assays such as Phenylketonuria monitoring, Adrenoleukodystrophy (ALD); established internal and external quality control programs. Planned, designed, performed, reported, presented, and supervised scientific projects on metabolic diseases, research and publications in Immunology, Molecular Biology, Environmental pollutants, and safety, with extensive experience in Endocrine disruptors and Newborn metabolic disorders. Assisting a supervising clinical laboratory scientist in the operation of a clinical laboratory unit resolving technical problems and developing recommendations on new or alternative equipment, methods, or materials in addition to performing regular clinical laboratory scientist duties, or assigning, training, reviewing and participating in the work of a group of clinical laboratory scientists engaged in the performance of a variety of standardized clinical laboratory tests in a specialized laboratory. Assists and supervising clinical laboratory scientist in the operation of a clinical laboratory unit by resolving technical problems and developing recommendations on new or alternative equipment, methods, or materials in addition to performing regular clinical laboratory scientist duties -OR- Assigns, trains, reviews and participates in the work of a group of clinical laboratory scientists engaged in the performance of a variety of standardized clinical laboratory tests.

PhD in Chemistry and Toxicology (Thesis on role of serine proteases in Angioedema and blood disorders), MSc Genetics and Biochemistry, BS: Physiology & Chemistry; postdoctoral research on cellular Biology and Breast Cancer (Role of metalloproteases in breast cancer).

Education:

- Ph.D., Chemistry/Toxicology, University of Paris VII, Paris, France Research pursued at Children’s Hospital in Cincinnati, Ohio

- M.Sc., Chemistry/Molecular Biology, University of Paris VI, Paris, France

- B.Sc., Biochemistry/Cell Biology, University of Paris VI, Paris, France

Certification

- Clinical Chemist Scientist (State of California)

- Technologist in Chemistry (American Society for Clinical Pathologist)

Work Experience:

May 2018- present

Department of Public Health, Genetic Disease Laboratory Branch (GDLB), Unit Chief, Supervising staff in a Clinical Laboratory

February 2009- May 2018

Department of Public Health, Environmental Health Laboratory Branch (EHLB), Research Scientist

Technical expertise:

Tandem Mass Spectrometry MS/MS; HPLC-MS, ICP-MS and GC-MS; ELISA, Northern and Western Blot analysis; Plasmid DNA procedures; Transformation and Transient Transfection; Cell culture of mammalian cell lines; Construction of mammalian cell lines expressing a variety of transient target proteins by DNA transfection; Immunohistochemistry; DNA/RNA extraction, expression vector construction, cloning, mutagenesis, primer design, PCR, RT-PCR, quantitative PCR, differential display, Real time PCR, transient and stable transfection

Publications (out of 10)

Berger, Kimberly; Kogut, Katherine; Bradman, Asa; She, Jianwen; Gavin, Qi; Zahedi, Rana; Parra, Kimberly; Harley, Kim. Personal care product use as a predictor of urinary concentrations of certain phthalates, parabens, and phenols in the HERMOSA study. Exposure Science & Environmental Epidemiology (January 2018)

Harley KG, Kogut K, Madrigal DS, Cardenas M, Vera IA, Meza-Alfaro G, She J, Gavin Q, Zahedi R, Bradman A, Eskenazi B, Parra KL (2016). Reducing phthalate, paraben, and phenol exposure from personal care products in adolescent girls: Findings from the HERMOSA intervention study. Environ Health Perspect DOI: 10.1289/ehp.1510514. Epub: 2016 March

Contact this candidate